T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Mettler-Toledo International
MTD
$28.5B
| $477M | 0.05% |
342,079
-102,391
| -23% | -$143M |
|
277
KeyCorp
KEY
$24.7B
| $469M | 0.05% |
22,721,443
-34,976,717
| -61% | -$651M |
|
|
WCN
278
Waste Connections
WCN
$41.6B
| $468M | 0.05% |
2,669,720
-695,028
| -21% | -$120M |
|
279
Royal Caribbean
RCL
$83B
| $458M | 0.05% |
1,640,646
+15,285
| +0.9% | +$4.32M |
|
280
Western Digital
WDC
$171B
| $450M | 0.05% |
2,611,856
+44,090
| +2% | +$6.69M |
|
281
Toll Brothers
TOL
$13.9B
| $447M | 0.05% |
3,303,915
+3,151,509
| +2,068% | +$428M |
|
282
Dominion Energy
D
$60.2B
| $444M | 0.05% |
7,580,443
-4,075,121
| -35% | -$246M |
|
283
Booz Allen Hamilton
BAH
$9.32B
| $440M | 0.05% |
5,217,184
-611,531
| -10% | -$54.7M |
|
284
MKS Inc
MKSI
$21.3B
| $440M | 0.05% |
2,753,850
-879,169
| -24% | -$130M |
|
285
Weyerhaeuser
WY
$17.9B
| $434M | 0.05% |
18,307,757
-6,447,129
| -26% | -$149M |
|
286
T. Rowe Price Total Return ETF
TOTR
$578M
| – | – |
0
| – | – |
|
287
Lazard
LAZ
$4.29B
| $428M | 0.05% |
8,807,320
+1,047,869
| +14% | +$52.3M |
|
288
Loews
L
$23.1B
| $420M | 0.05% |
3,984,234
+344,995
| +9% | +$35.6M |
|
|
ONC
289
BeOne Medicines Ltd
ONC
$40.3B
| $417M | 0.05% |
1,372,679
-257,892
| -16% | -$84.4M |
|
290
Quanta Services
PWR
$102B
| $413M | 0.04% |
979,087
-60,573
| -6% | -$26.6M |
|
291
Lamb Weston
LW
$7.39B
| $412M | 0.04% |
9,824,690
+2,111,874
| +27% | +$124M |
|
292
T. Rowe Price Growth ETF
TGRT
$1.59B
| $411M | 0.04% |
9,260,089
+1,010,365
| +12% | +$44.7M |
|
|
PR
293
Permian Resources
PR
$17.7B
| $409M | 0.04% |
29,147,063
-6,850,832
| -19% | -$92M |
|
294
United Parcel Service
UPS
$89.7B
| $406M | 0.04% |
4,092,370
-315,354
| -7% | -$29.5M |
|
295
Weatherford International
WFRD
$6.6B
| $404M | 0.04% |
5,156,773
+281,984
| +6% | +$20.5M |
|
296
Installed Building Products
IBP
$6.54B
| $402M | 0.04% |
1,551,161
+328,725
| +27% | +$85M |
|
|
SARO
297
StandardAero Inc
SARO
$9.03B
| $402M | 0.04% |
14,000,143
+3,540,167
| +34% | +$96.4M |
|
298
BrightSpring Health Services
BTSG
$12B
| $399M | 0.04% |
10,662,236
+478,436
| +5% | +$16M |
|
299
News Corp Class A
NWSA
$15.6B
| $399M | 0.04% |
15,285,794
-1,443,796
| -9% | -$37.9M |
|
300
Jones Lang LaSalle
JLL
$16.8B
| $397M | 0.04% |
1,180,514
+178,677
| +18% | +$56M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.